Beone Medicines USA, INC. (FKA Beigene USA, INC.)
Biopharmaceutical company.
Based in MA
🤖
AI Overview
With $1.8M in lobbying spend across 30 quarterly filings, Beone Medicines USA, INC. (FKA Beigene USA, INC.) is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2020 to 2025.
$1.8M
Total Spend
6
Years Active
1
Firms Hired
8
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $40K |
| 2021 | $480K |
| 2022 | $420K |
| 2023 | $280K |
| 2024 | $280K |
| 2025 | $280K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Health Issues, Medicare/Medicaid, Manufacturing, Budget/Appropriations
- •Issues affecting the pharmaceutical industry; issues related to trade.
- •Monitoring activities related to trade
- •Monitoring activities related to drug policy
- •Monitoring activities related to drug policy.
Related Analysis
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.